Who backs Allyx Therapeutics?
10 investors| Investor | Type |
|---|---|
| National Institutes of Health | Other |
| Connecticut Innovations | Venture capital |
| Bristol-Myers Squibb | — |
| Spring Mountain Capital | Growth equity |
| Elm Street Ventures | — |
| Harrington Discovery Institute/University Health Holdings | — |
| Life Science Angels | — |
| The National Institute on Aging (NIA) | — |
| U.S. Department of Health and Human Services | — |
| University of Connecticut Technology Incubation Program | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Allyx Therapeutics investors
10 investors are on record for Allyx Therapeutics, including National Institutes of Health, Connecticut Innovations, Bristol-Myers Squibb and Spring Mountain Capital. The early-stage round in May 2026 drew 32 investors.
Free account
More of Allyx Therapeutics with a free account
- ·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 10 firms already write checks for companies like Allyx Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View